DnB Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $55.2M | Buy |
1,965,182
+212,096
| +12% | +$5.65M | 0.2% | 87 |
|
|
2025
Q4 | $43.7M | Buy |
1,753,086
+486,895
| +38% | +$12.3M | 0.15% | 95 |
|
|
2025
Q3 | $32.3M | Sell |
1,266,191
-25,566
| -2% | -$631K | 0.12% | 128 |
|
|
2025
Q2 | $31.3M | Buy |
1,291,757
+99,031
| +8% | +$2.31M | 0.13% | 120 |
|
|
2025
Q1 | $30.2M | Sell |
1,192,726
-700,670
| -37% | -$18.3M | 0.14% | 120 |
|
|
2024
Q4 | $50.2M | Buy |
1,893,396
+352,515
| +23% | +$9.56M | 0.22% | 73 |
|
|
2024
Q3 | $44.6M | Buy |
1,540,881
+96,356
| +7% | +$2.81M | 0.2% | 87 |
|
|
2024
Q2 | $40.4M | Buy |
1,444,525
+83,153
| +6% | +$2.29M | 0.19% | 83 |
|
|
2024
Q1 | $37.8M | Sell |
1,361,372
-1,866,024
| -58% | -$51.8M | 0.2% | 88 |
|
|
2023
Q4 | $92.9M | Buy |
3,227,396
+153,719
| +5% | +$4.65M | 0.48% | 38 |
|
|
2023
Q3 | $102M | Buy |
3,073,677
+138,558
| +5% | +$4.9M | 0.61% | 27 |
|
|
2023
Q2 | $108M | Buy |
2,935,119
+54,410
| +2% | +$2.12M | 0.62% | 32 |
|
|
2023
Q1 | $118M | Buy |
2,880,709
+34,088
| +1% | +$1.47M | 0.75% | 25 |
|
|
2022
Q4 | $146M | Buy |
2,846,621
+14,783
| +0.5% | +$709K | 1.03% | 15 |
|
|
2022
Q3 | $124M | Sell |
2,831,838
-30,579
| -1% | -$1.49M | 0.96% | 17 |
|
|
2022
Q2 | $150M | Sell |
2,862,417
-170,863
| -6% | -$8.71M | 1.06% | 14 |
|
|
2022
Q1 | $157M | Buy |
3,033,280
+817,416
| +37% | +$42.4M | 0.93% | 17 |
|
|
2021
Q4 | $131M | Sell |
2,215,864
-32,857
| -1% | -$1.63M | 0.77% | 20 |
|
|
2021
Q3 | $96.7M | Sell |
2,248,721
-24,311
| -1% | -$1.08M | 0.63% | 28 |
|
|
2021
Q2 | $89M | Buy |
2,273,032
+114,370
| +5% | +$4.45M | 0.59% | 27 |
|
|
2021
Q1 | $78.2M | Sell |
2,158,662
-1,330,821
| -38% | -$47.3M | 0.57% | 30 |
|
|
2020
Q4 | $128M | Sell |
3,489,483
-388,744
| -10% | -$14.3M | 1.13% | 14 |
|
|
2020
Q3 | $135M | Sell |
3,878,227
-575,607
| -13% | -$20.2M | 1.44% | 14 |
|
|
2020
Q2 | $138M | Sell |
4,453,834
-192,916
| -4% | -$6.55M | 1.62% | 10 |
|
|
2020
Q1 | $144M | Buy |
4,646,750
+1,276,578
| +38% | +$43.5M | 2.12% | 9 |
|
|
2019
Q4 | $125M | Sell |
3,370,172
-565,510
| -14% | -$20.1M | 1.23% | 17 |
|
|
2019
Q3 | $134M | Buy |
3,935,682
+2,781,372
| +241% | +$101M | 1.51% | 12 |
|
|
2019
Q2 | $47.4M | Buy |
1,154,310
+21,134
| +2% | +$839K | 0.55% | 39 |
|
|
2019
Q1 | $45.7M | Sell |
1,133,176
-96,925
| -8% | -$3.88M | 0.52% | 40 |
|
|
2018
Q4 | $50.9M | Sell |
1,230,101
-185,766
| -13% | -$7.71M | 0.66% | 35 |
|
|
2018
Q3 | $59.2M | Buy |
1,415,867
+123,305
| +10% | +$4.75M | 0.67% | 36 |
|
|
2018
Q2 | $44.5M | Buy |
1,292,562
+73,990
| +6% | +$2.53M | 0.53% | 42 |
|
|
2018
Q1 | $41M | Buy |
1,218,572
+279,205
| +30% | +$9.6M | 0.49% | 45 |
|
|
2017
Q4 | $32.3M | Buy |
939,367
+288,099
| +44% | +$9.82M | 0.39% | 55 |
|
|
2017
Q3 | $22.1M | Sell |
651,268
-320,676
| -33% | -$10.3M | 0.29% | 74 |
|
|
2017
Q2 | $31M | Buy |
971,944
+27,720
| +3% | +$874K | 0.45% | 52 |
|
|
2017
Q1 | $30.6M | Sell |
944,224
-1,230,802
| -57% | -$38.8M | 0.48% | 51 |
|
|
2016
Q4 | $67M | Sell |
2,175,026
-780,276
| -26% | -$23.8M | 1.23% | 17 |
|
|
2016
Q3 | $95M | Buy |
2,955,302
+27,615
| +0.9% | +$923K | 1.87% | 7 |
|
|
2016
Q2 | $97.8M | Buy |
2,927,687
+264,870
| +10% | +$8.45M | 2.07% | 9 |
|
|
2016
Q1 | $74.9M | Buy |
2,662,817
+409,268
| +18% | +$11.7M | 1.56% | 13 |
|
|
2015
Q4 | $69M | Sell |
2,253,549
-178,716
| -7% | -$5.62M | 1.48% | 16 |
|
|
2015
Q3 | $72.5M | Buy |
2,432,265
+205,211
| +9% | +$6.58M | 1.81% | 11 |
|
|
2015
Q2 | $70.8M | Buy |
2,227,054
+277,960
| +14% | +$9.06M | 1.56% | 13 |
|
|
2015
Q1 | $64.3M | Sell |
1,949,094
-1,176,664
| -38% | -$37.4M | 1.43% | 16 |
|
|
2014
Q4 | $92.4M | Buy |
3,125,758
+78,454
| +3% | +$2.25M | 2.09% | 6 |
|
|
2014
Q3 | $85.5M | Buy |
3,047,304
+2,542,479
| +504% | +$71.4M | 1.88% | 9 |
|
|
2014
Q2 | $14.2M | Buy |
+504,825
| New | +$14.4M | 0.3% | 72 |
|
|
2013
Q4 | $15.8M | Buy |
544,855
+220,075
| +68% | +$6.41M | 0.37% | 67 |
|
|
2013
Q3 | $8.85M | Sell |
324,780
-1,899,064
| -85% | -$51.7M | 0.24% | 76 |
|
|
2013
Q2 | $59.1M | Buy |
+2,223,844
| New | +$61.4M | 1.75% | 12 |
|
Other funds holding PFE
VCM
VPM
DnB Asset Management's PFE Position: Q1 2026 in Review
DnB Asset Management increased its Pfizer (PFE) stake by 12% in Q1 2026, buying an estimated $5.65M and bringing the position to 1,965,182 shares worth $55.2M. The position accounts for 0.2% of the portfolio, ranked #87.
DnB Asset Management first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $157M in Q1 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- DnB Asset Management held 1,965,182 shares of Pfizer worth $55.2M as of Q1 2026.
- DnB Asset Management bought 212,096 Pfizer shares in Q1 2026, an estimated $5.65M.
- Pfizer made up 0.2% of DnB Asset Management's portfolio in Q1 2026, its #87 holding.
- DnB Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- DnB Asset Management's Pfizer position peaked at $157M in Q1 2022.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on DnB Asset Management's 13F filing for Q1 2026, filed 14 May 2026.